|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1201 Maryland Avenue SW |
Address2 | Suite 900 |
City | Washington |
State | DC |
Zip Code | 20024 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 6245-12
|
||||||||
|
6. House ID# 325050000
|
TYPE OF REPORT | 8. Year | 2013 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Brent DelMonte, Vice President for Federal Government Relations |
Date | 01/26/2015 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
USDA/APHIS Agricultural Biotechnology Regulations
Efficient Science-Based Review of Biotech Products
National Environmental Policy Act Requirements
USDA Decision on GE Crops Environmental Impact Statement
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
Amendment on GE Crop Field Trials/Compensation Fund
S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
EPA Regulations on Agricultural Biotechnology
Coordination with USDA on Approvals
Reauthorization and Implementation of Pesticide Registration Improvement Act
Export Registrations for Products with Expired Patents
Fish and Wildlife Service Policy on Planting of Biotech Crops
Labeling of Genetically Engineered Crops
U.S. Government Policy
S. 1244/H.R. 2410: Agriculture, Rural Development, FDA, and Related Appropriations Act for FY 2014
TransPacific Partnership
Sanitary and Phytosanitary Issues
Funding for the USDA (Office of General Counsel, Biotechnology Regulatory Services, National Institute of Food and Agriculture, APHIS, Trade Activities (Office of the Secretary & Food Safety Inspection Service), National Resources Conservation Service, Agriculture Research Service, Biofuels, Foreign Agriculture Service)
H.R. 2410/S. 1244: Agriculture Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014
Foreign Agricultural Biotechnology Laws and Regulations
Asynchrony of International Approvals
China Biotechnology Regulations
Low-Level Presence Foreign Government Policies
Agricultural Biotechnology Regulatory Reform and Modernization
Benefits of Ag-Biotech Research and Innovation
Biomass Programs
Reauthorization of Biomass Crop Assistance Program
Reauthorization of Biomass R&D Program
S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
Transatlantic Trade and Investment Partnership
Ag-Biotech Issues
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), U.S. Trade Representative (USTR), White House Office, Environmental Protection Agency (EPA), Office of Science & Technology Policy (OSTP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cathleen |
Enright |
|
|
|
David |
Edwards |
|
|
|
Tracey |
LaTurner |
|
|
|
Dana |
O'Brien |
|
|
|
Matthew |
Carr |
|
|
|
Brent |
Del Monte |
|
|
|
Erick |
Lutt |
|
|
|
Matthew |
O'Mara |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ANI
16. Specific lobbying issues
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
Genetically Engineered (GE) Animals
FDA Approval
Labeling
S. 1244/H.R. 2410: Agriculture, Rural Development, FDA, and Related Appropriations Act for FY 2014
Amendment on GE Salmon Labeling (Senate)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cathleen |
Enright |
|
|
|
Dana |
O'Brien |
|
|
|
David |
Edwards |
|
|
|
Brent |
DelMonte |
|
|
|
. |
. |
|
|
|
. |
. |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
S. 1284: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014
Funding for the USDA (Office of General Counsel, Biotechnology Regulatory Services, National Institute of Food and Agriculture, APHIS, Trade Activities (Office of the Secretary & Food Safety Inspection Service), National Resources Conservation Service, Agriculture Research Service, Biofuels, Foreign Agriculture Service)
H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations for FY 2014
Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure)
H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014
Funding for Centers for Disease Control and Prevention Vaccine Programs
S. 1284: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014
Funding for National Institutes of Health
S. 1284: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014
Sequestration of PDUFA Fees
Implementation of S. 365: Budget Control Act
H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014
HR 2725: Food and Drug Administration Safety Over Sequestration Act of 2013
S. 1413: FDA User Fee Protection Act
H.J. Res 59: Continuing Appropriations Act for FY 2014
Funding for Renewable Chemicals/Bio-based Products
Expansion of Biorefinery Assistance Program to Renewable Chemicals and Bio-based Products
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.J. Res 59: Continuing Appropriations Act for FY 2014
Funding for Biofuels
Energy and Water Development and Related Agencies Appropriations Act for FY 2014
H.R. 2397: Department of Defense Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014
Funding for Biorefineries
Reauthorization/Funding of Biorefinery Grant and Loan Programs
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.J. Res 59: Continuing Appropriations Act for FY 2014
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tracey |
LaTurner |
|
|
|
Matthew |
Carr |
|
|
|
Anna |
Weinstein |
|
|
|
Andrew |
Emmett |
|
|
|
Catharine |
Harris |
|
|
|
Brent |
DelMonte |
|
|
|
Derrick |
White |
|
|
|
Sara |
Radcliffe |
|
|
|
Jeanne |
Haggerty |
|
|
|
Kelly |
Cappio |
|
|
|
Erick |
Lutt |
|
|
|
Cartier |
Esham |
|
|
|
Rina |
Singh |
|
|
|
Phyllis |
Arthur |
|
|
|
Matthew |
Schumaker |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
Intellectual Property International Enforcement
Compulsory Licensing
Patent Reform
Implementation of H.R. 1249: The America Invents Act of 2011
H.R. 2024: End Anonymous Patents Act
H.R. 845: The SHIELD Act of 2013
S. 1013: Patent Abuse Reduction Act of 2013
S. 866: Patent Quality Improvement Act of 2013
House Judiciary Committee Discussion Draft
DNA Patenting and Licensing
TransPacific Partnership
Data and Intellectual Property Protections for Pharmaceuticals
Transatlantic Trade and Investment Partnership
Intellectual Property Issues
Asia Pacific Economic Cooperation Forum
Biologics Regulations
Export Registrations for Products With Expired Patents
Genetic Resource Patent Disclosure Requirement
World Intellectual Property Organization
Clinical Trial Data Sharing
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, U.S. Trade Representative (USTR), Agriculture - Dept of (USDA), Executive Office of the President (EOP), Food & Drug Administration (FDA), Patent & Trademark Office (PTO), State - Dept of (DOS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Andrew |
Emmett |
|
|
|
Hans |
Sauer |
|
|
|
Jeanne |
Haggerty |
|
|
|
Brent |
Del Monte |
|
|
|
Tom |
DiLenge |
|
|
|
Joseph |
Damond |
|
|
|
Charles |
Fritts |
|
|
|
Anna |
Weinstein |
|
|
|
Derrick |
White |
|
|
|
Matthew |
Schumaker |
|
|
|
Matthew |
O'Mara |
|
|
|
Sara |
Radcliffe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
Labeling of Genetically Engineered Crops
U.S. Government Policy
S. 1244/H.R. 2410: Agriculture, Rural Development, FDA, and Related Appropriations Act for FY 2014
USDA/APHIS Agricultural Biotechnology Regulations
Efficient Science-Based Review of Biotech Products
National Environmental Policy Act Requirements
USDA Decision on GE Crops Environmental Impact Statement
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
Amendment on GE Crop Field Trials/Compensation Fund
S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
Genetically Engineered (GE) Animals
FDA Approval
Labeling
S. 1244/H.R. 2410: Agriculture, Rural Development, FDA, and Related Appropriations Act for FY 2014
Amendment on GE Salmon Labeling (Senate)
Drug Safety and Review
PDUFA V Implementation
FDA Safety and Innovation Act Implementation
Supply Chain Integrity
Special Medical Use/Limited Population Drugs
Pharmacy Compounding
S. 957: Drug Supply Chain Security Act,
S.959: Pharmaceutical Compounding Quality Act
H.R. 1919: The Safeguarding America Pharmaceuticals Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), U.S. Trade Representative (USTR), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cathleen |
Enright |
|
|
|
David |
Edwards |
|
|
|
Andrew |
Emmett |
|
|
|
Anna |
Weinstein |
|
|
|
Sara |
Radcliffe |
|
|
|
Jeanne |
Haggerty |
|
|
|
Derrick |
White |
|
|
|
Dana |
O'Brien |
|
|
|
Matthew |
Schumaker |
|
|
|
Tom |
DiLenge |
|
|
|
Brent |
DelMonte |
|
|
|
Alan |
Eisenberg |
|
|
|
Cartier |
Esham |
|
|
|
. |
. |
|
|
|
. |
. |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENG
16. Specific lobbying issues
Biorefineries
Reauthorization of Biorefinery Assistance Program
Reauthorization/Funding of Biorefinery Grant and Loan Programs
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
Biorefineries Cont...
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.J. Res 59: Continuing Appropriations Act for FY 2014
Biofuels
Accelerated Depreciation Extension
Climate Change Benefits
Production Tax Credit Extension
Renewable Fuel Standard
Implementation
Regulatory Oversight
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 1284: Energy and Water Development and Related Agencies Appropriations Act for FY 2014
H.R. 2397: Department of Defense Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014
Renewable Chemicals/Bio-based Products
Expansion of Biorefinery Assistance Program to Renewable Chemicals and Bio-based Products
Expansion of Master Limited Partnerships to Renewable Chemicals
New Production Tax Credit for Renewable Chemicals
Reauthorization of USDA Bio-Preferred Program
H.R. 1696/S. 795: Master Limited Partnerships Parity Act
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
H.R. 2421: Renewable Chemicals Parity Act
S. 1267/H.R. 3084: Renewable Chemical Production Tax Credit Act
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.J. Res 59: Continuing Appropriations Act for FY 2014
Biomass Programs
Reauthorization of Biomass Crop Assistance Program
Reauthorization of Biomass R&D Program
S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office, Environmental Protection Agency (EPA), Agriculture - Dept of (USDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Carr |
|
|
|
Dana |
O'Brien |
|
|
|
Tracey |
LaTurner |
|
|
|
Charles |
Fritts |
|
|
|
Rina |
Singh |
|
|
|
Brent |
Del Monte |
|
|
|
Erick |
Lutt |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
Genetically Engineered (GE) Animals
FDA Approval
Labeling
S. 1244/H.R. 2410: Agriculture, Rural Development, FDA, and Related Appropriations Act for FY 2014
Amendment on GE Salmon Labeling (Senate)
Labeling of Genetically Engineered Crops
U.S. Government Policy
S. 1244/H.R. 2410: Agriculture, Rural Development, FDA, and Related Appropriations Act for FY 2014
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cathleen |
Enright |
|
|
|
David |
Edwards |
|
|
|
Dana |
O'Brien |
|
|
|
Tracey |
LaTurner |
|
|
|
Brent |
Del Monte |
|
|
|
. |
. |
|
|
|
. |
. |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FUE
16. Specific lobbying issues
Biorefineries
Reauthorization of Biorefinery Assistance Program
Reauthorization/Funding of Biorefinery Grant and Loan Programs
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
Biorefineries Cont...
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.J. Res 59: Continuing Appropriations Act for FY 2014
Biofuels
Accelerated Depreciation Extension
Climate Change Benefits
Production Tax Credit Extension
Renewable Fuel Standard
Implementation
Regulatory Oversight
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 1284: Energy and Water Development and Related Agencies Appropriations Act for FY 2014
H.R. 2397: Department of Defense Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014
Renewable Chemicals/Bio-based Products
Expansion of Biorefinery Assistance Program to Renewable Chemicals and Bio-based Products
Expansion of Master Limited Partnerships to Renewable Chemicals
New Production Tax Credit for Renewable Chemicals
Reauthorization of USDA Bio-Preferred Program
H.R. 1696/S. 795: Master Limited Partnerships Parity Act
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
H.R. 2421: Renewable Chemicals Parity Act
S. 1267/H.R. 3084: Renewable Chemical Production Tax Credit Act
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.J. Res 59: Continuing Appropriations Act for FY 2014
Biomass Programs
Reauthorization of Biomass Crop Assistance Program
Reauthorization of Biomass R&D Program
S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office, Agriculture - Dept of (USDA), Environmental Protection Agency (EPA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Carr |
|
|
|
Dana |
O'Brien |
|
|
|
Tracey |
LaTurner |
|
|
|
Charles |
Fritts |
|
|
|
Rina |
Singh |
|
|
|
Brent |
DelMonte |
|
|
|
Erick |
Lutt |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Vaccine Access/Financing
Adult Immunization (Senate Discussion Draft)
Biosimilars
Colombia Biologics Regulations
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Interchangeability and Pharmacy Substitution
Funding for National Institutes of Health
S. 1284: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014
Funding for Centers for Disease Control and Prevention Vaccine Programs
S. 1284: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014
340B Drug Pricing Program
HRSA Implementation of Program Changes
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
S.1284: Department of Labor, HHS, Education, and Related Agencies Appropriations Act of 2014
Expanded Access to Experimental Products
FDA Rules
Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) (2)
H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014
Independent Payment Advisory Board
S.351/H.R. 351: Protecting Seniors' Access to Medicare Act of 2013
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
S. 1284: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014
TransPacific Partnership
Data and Intellectual Property Protection for Pharmaceuticals
Regulatory Harmonization
Reimbursement for Innovative Products
Medicare Part B Physician-Administered Products
Medicare Part D Prescription Drug Program
H.R. 1416: Cancer Patient Protection Act of 2013
National Center for Advancing Translational Science (NCATS)
Funding
Program Implementation
Asia Pacific Economic Cooperation Forum
Biologics Regulation
Transatlantic Trade and Investment Partnership
Intellectual Property Issues
Regulatory Harmonization
Sequestration of PDUFA Fees
Implementation of S. 365: Budget Control Act
H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and related agencies Appropriations Act FY 2014
H.R. 2725: Food and Drug Administration Safety Over Sequestration Act of 2013
S. 1413: FDA User Fee Protection Act
H.J. Res 59: Continuing Appropriations Act for FY 2014
Drug Safety and Review
PDUFA V Implementation
FDA Safety and Innovation Act Implementation
Supply Chain Integrity
Special Medical Use/Limited Population Drugs
Pharmacy Compounding
S. 957: Drug Supply Chain Security Act,
S.959: Pharmaceutical Compounding Quality Act
H.R. 1919: The Safeguarding America Pharmaceuticals Act
Orphan Drug Act Issues
Tax Credit
Clinical Trial Data Sharing
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, U.S. Trade Representative (USTR), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), State - Dept of (DOS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Catharine |
Harris |
|
|
|
Andrew |
Emmett |
|
|
|
Hans |
Sauer |
|
|
|
Matthew |
Schumaker |
|
|
|
Jeanne |
Haggerty |
|
|
|
Sara |
Radcliffe |
|
|
|
Phyllis |
Arthur |
|
|
|
Anna |
Weinstein |
|
|
|
Derrick |
White |
|
|
|
Tom |
DiLenge |
|
|
|
Tracey |
LaTurner |
|
|
|
Laurel |
Todd |
|
|
|
Kelly |
Cappio |
|
|
|
Brent |
DelMonte |
|
|
|
Cartier |
Esham |
|
|
|
Alan |
Eisenberg |
|
|
|
Shelly |
Mui-Lipnik |
|
|
|
Charles |
Crain |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HOM
16. Specific lobbying issues
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
S. 1284: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sara |
Radcliffe |
|
|
|
Phyllis |
Arthur |
|
|
|
Tracey |
LaTurner |
|
|
|
Kelly |
Cappio |
|
|
|
Brent |
DelMonte |
|
|
|
Jeanne |
Haggerty |
|
|
|
Derrick |
White |
|
|
|
Matthew |
Schumaker |
|
|
|
Anna |
Weinstein |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Funding for National Institutes of Health
S. 1284: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
S. 1284: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014
National Center for Advancing Translational Science (NCATS)
Funding
Program Implementation
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cartier |
Esham |
|
|
|
Jeanne |
Haggerty |
|
|
|
Kelly |
Cappio |
|
|
|
Phyllis |
Arthur |
|
|
|
Tracey |
LaTurner |
|
|
|
Brent |
DelMonte |
|
|
|
Matthew |
Schumaker |
|
|
|
Derrick |
White |
|
|
|
Anna |
Weinstein |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Independent Payment Advisory Board
S.351/H.R. 351: Protecting Seniors' Access to Medicare Act of 2013
Reimbursement for Innovative Products
Medicare Part B Physician-Administered Products
Medicare Part D Prescription Drug Program
H.R. 1416: Cancer Patient Protection Act of 2013
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Brent |
DelMonte |
|
|
|
Derrick |
White |
|
|
|
Matthew |
Schumaker |
|
|
|
Jeanne |
Haggerty |
|
|
|
Catharine |
Harris |
|
|
|
. |
. |
|
|
|
. |
. |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SMB
16. Specific lobbying issues
Stock Exchange Tick Size
Tick Size Flexibility Act (Rep. Duffy Discussion Draft)
H.R. 1952: The Spread Pricing Liquidity Act
Sarbanes Oxley Section 404 (b)
Mandatory Audit Firm Rotation
H.R. 1564: The Audit Integrity and Job Protection Act
S. 1526: The Audit Integrity and Job Protection Act
Capital Formation Investment Incentives
Reform of Capital Gains Rules
Reform of Net Operating Loss Rules
Reform of Passive Loss Rules
H.R. 6559/S.3595: High Technology Small Business Research Incentives Act
Reform of SEC Regulation D
Implementation of Jumpstart Our Business Start-ups (JOBS) Act
Expansion of Exemption Under SEC Regulation A
H.R. 701: To amend a provision of the Securities Act of 1933 directing the Securities and Exchange Commission to
add a particular class of securities to those exempted under such Act to provide a deadline
for such action
Rep. McHenry Discussion Draft
Legislative Amendments to SEC Rule 12b-2 Filing Status Definitions
H.R. 2629: Fostering Innovation Act
Market Structure Reform for Small Companies
XBRL Exemption for Small Public Companies
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Small Business Adminstration (SBA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Charles |
Crain |
|
|
|
Charles |
Fritts |
|
|
|
Alan |
Eisenberg |
|
|
|
Shelly |
Mui-Lipnik |
|
|
|
Brent |
DelMonte |
|
|
|
Tom |
DiLenge |
|
|
|
Derrick |
White |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Biofuels
Production Tax Credit Extension
Accelerated Depreciation Extension
Renewable Chemicals/Bio-based Products
Expansion of Master Limited Partnerships to Renewable Chemicals
New Production Tax Credit for Renewable Chemicals
S. 1267/H.R. 3084: Renewable Chemical Production Tax Credit Act
H.R. 1696/S. 795: Master Limited Partnerships Parity Act
Research & Development Tax Credit Reforms
Startup Innovation Credit (Senator Coons Discussion Draft)
Innovative Research and Competitiveness Act (Senator Carper Discussion Draft)
H.R.119: To amend the Internal Revenue Code to make permanent the credit for increasing research activities
Capital Formation Investment Incentives
Reform of Capital Gains Rules
Reform of Net Operating Loss Rules
Reform of Passive Loss Rules
H.R. 6559/S.3595: High Technology Small Business Research Incentives Act
Tax Reform
Orphan Drug Act Issues
Tax Credit
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Treasury - Dept of, Small Business Adminstration (SBA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Carr |
|
|
|
Shelly |
Mui-Lipnik |
|
|
|
Anna |
Weinstein |
|
|
|
Tom |
DiLenge |
|
|
|
Rina |
Singh |
|
|
|
Charles |
Fritts |
|
|
|
Charles |
Crain |
|
|
|
Dana |
O'Brien |
|
|
|
Alan |
Eisenberg |
|
|
|
Derrick |
White |
|
|
|
Brent |
Del Monte |
|
|
|
Matthew |
Schumaker |
|
|
|
Erick |
Lutt |
|
|
|
. |
. |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
Intellectual Property International Enforcement
Compulsory Licensing
Foreign Agricultural Biotechnology Laws and Regulations
Asynchrony of International Approvals
China Biotechnology Regulations
Low-Level Presence Foreign Government Policies
TransPacific Partnership
Data and Intellectual Property Protection for Pharmaceuticals
Intellectual Property Issues
Regulatory Transparency
Transatlantic Trade and Investment Partnership
Ag-Biotech Issues
Intellectual Property Issues
Regulatory Harmonization
Asia Pacific Economic Cooperation Forum
Biologics Regulations
Biosimilars
Colombia Biologics Regulations
Genetic Resource Patent Disclosure Requirement
World Intellectual Property Organization
Clinical Trial Data Sharing
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, U.S. Trade Representative (USTR), Agriculture - Dept of (USDA), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Patent & Trademark Office (PTO), State - Dept of (DOS), Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tom |
DiLenge |
|
|
|
David |
Edwards |
|
|
|
Sara |
Radcliffe |
|
|
|
Brent |
DelMonte |
|
|
|
Joseph |
Damond |
|
|
|
Jeanne |
Haggerty |
|
|
|
Charles |
Fritts |
|
|
|
Matthew |
O'Mara |
|
|
|
Cathleen |
Enright |
|
|
|
Andrew |
Emmett |
|
|
|
Hans |
Sauer |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address: BIO maintains a list of all of its members on its website at http://bio.org/membership/index.asp
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |